Rankings
▼
Calendar
ANIP FY 2017 Earnings — ANI Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
ANIP
ANI Pharmaceuticals, Inc.
$2B
FY 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$177M
+37.5% YoY
Gross Profit
$98M
55.3% margin
Operating Income
$28M
16.0% margin
Net Income
-$1M
-0.6% margin
EPS (Diluted)
$-0.09
Cash Flow
Operating Cash Flow
$39M
Free Cash Flow
-$69M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$412M
Total Liabilities
$237M
Stockholders' Equity
$175M
Cash & Equivalents
$31M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$177M
$129M
+37.5%
Gross Profit
$98M
$80M
+22.5%
Operating Income
$28M
$20M
+41.1%
Net Income
-$1M
$4M
-127.4%
← Q4 2016
All Quarters
Q1 2017 →